论文部分内容阅读
[目的]观察丹红注射液辅助治疗重症肺源性心脏病的疗效。[方法]将60例患者随机分为治疗组(30例)和对照组(30例),两组均予西医内科常规治疗(包括吸氧、抗炎、止咳、祛痰、平喘、强心、利尿等),治疗组在上述基础上加用丹红注射液30mL并加入5%葡萄糖注射液250mL中静滴,每日1次,2周为1个疗程。[结果]治疗组的临床疗效总有效率优于对照组(P<0.05);治疗组PaO_2、PaCO_2较对照组明显改善(P<0.01)。[结论]丹红注射液能有效降低肺心病患者血液黏稠度,降低肺循环阻力,从而改善心肺功能.缩短住院时间,值得推广。
[Objective] To observe the effect of Danhong injection in the treatment of severe cor pulmonale. [Methods] Sixty patients were randomly divided into treatment group (30 cases) and control group (30 cases). Both groups were treated routinely with Western medicine including oxygen, anti-inflammatory, cough, expectorant, , Diuresis, etc.). On the basis of the above, the treatment group added Danhong injection 30mL and added intravenous infusion of 250mL of 5% glucose injection once daily for 2 weeks for one course of treatment. [Results] The total effective rate of the treatment group was better than that of the control group (P <0.05). The PaO_2 and PaCO_2 of the treatment group were significantly improved compared with the control group (P <0.01). [Conclusion] Danhong injection can effectively reduce the blood viscosity of patients with cor pulmonale and reduce the resistance of pulmonary circulation so as to improve the cardiopulmonary function, shorten the length of hospital stay, and be worth popularizing.